Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Myelodysplastic Syndromes 48Leukemia, Myeloid, Acute 43Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Leukemia, Myelogenous, Chronic, BCR-ABL Positive 22Leukemia 19Hodgkin Disease 18Lymphoma, Non-Hodgkin 17Multiple Myeloma 14Leukemia, Lymphocytic, Chronic, B-Cell 13Primary Myelofibrosis 12Leukemia, Myelomonocytic, Chronic 11Myeloproliferative Disorders 10Lymphoma 10Graft vs Host Disease 8Leukemia, Biphenotypic, Acute 7Leukemia, Myelomonocytic, Juvenile 6Polycythemia Vera 4Lymphoma, Follicular 4Leukemia, Myeloid, Accelerated Phase 4Hemoglobinuria, Paroxysmal 4Anemia, Aplastic 4Thrombocythemia, Essential 3Neoplasms 3Lymphoma, Mantle-Cell 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, B-Cell, Marginal Zone 3Hematologic Neoplasms 3Hematologic Diseases 3Blast Crisis 3Anemia, Refractory, with Excess of Blasts 3

Interventions

fludarabine 2Tacrolimus 2fludarabine phosphate 1Whole-Body Irradiation 1Stem Cell Transplantation 1Mycophenolic Acid 1Cyclophosphamide 1Busulfan 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Paraproteinemias × Stem Cell Transplantation × Myeloid × Clear all
NCT00579111 2016-05-04

Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)

Baylor College of Medicine

Phase 1/2 Terminated
4 enrolled 8 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hematologic Diseases, Lymphoproliferative Disorders, Multiple Myeloma, Myeloproliferative Disorders, Paraproteinemias, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡